Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10143-10150
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10143
Table 4 Major adverse cardiovascular events rate in patients with different SYNTAX risk scores receiving different treatments, n (%)
SYNTAX risk scores (points)
n
Medication group
Stent group
CABG group
Overall MACE rate
Hc value
P value
n
MACE rate
n
MACE rate
n
MACE rate
Low risk group (0-22)33018530 (16.2)13046 (35.4)159 (60.0)85 (25.8)12.2130.001
Intermediate risk group (23-32)4283 (37.5)229 (40.9)125 (41.7)17 (40.5)1.9840.214
High risk group (≥ 33)1421 (50.0)43 (75.0)82 (25.0)6 (42.9)8.4320.014
Total38619536 (18.5)15657 (36.5)3515 (42.9)108 (28.0)4.4120.044